Literature DB >> 27138949

Prevalence of antenatal depression and associated factors among pregnant women hospitalized in a high-risk pregnancy unit in Greece.

Themistoklis Dagklis1, Georgios Papazisis2, Ioannis Tsakiridis1, Foteini Chouliara1, Apostolos Mamopoulos1, David Rousso1.   

Abstract

PURPOSE: Women who face pregnancy complications may require hospitalization in a high-risk pregnancy unit (HRPU), and this may have a negative impact on the pregnant woman's mental health. The purpose of this study was to screen for depressive symptoms in pregnant women admitted in a high-risk pregnancy unit and also to investigate associated risk factors.
METHODS: This was a cross-sectional study that enrolled pregnant women admitted at ≥24 gestational weeks in a university hospital HRPU, between September 2014 and November 2015. The Edinburgh Postnatal Depression Scale was used to assess depressive symptoms on admission. A cutoff score ≥13 was considered as indicative of depression. Test results were then correlated with the reasons that led to the women's admission as well as socio-demographic characteristics.
RESULTS: Overall, 157 of the women admitted in the HRPU during the study period were eligible for the study and agreed to complete the questionnaire. The mean age of the pregnant women was 30 ± 6 years, and the mean gestational week at admission was 32 ± 3 weeks. The prevalence of antenatal depression (score ≥13) was 28 % (44/157). In the multivariate analysis, antenatal depression was significantly correlated with smoking (OR = 2.681, 95 % CI 1.089-6.601) and the existence of thoughts for pregnancy termination (OR = 3.624, 95 % CI 1.149-11.427).
CONCLUSIONS: Approximately one quarter of pregnant women hospitalized in the HRPU may show signs of depression at the time of admission. Smoking and an unwanted pregnancy were found to be independently associated with antenatal depression, whereas no association was found with any obstetric parameters.

Entities:  

Keywords:  Antenatal depression; Edinburgh postnatal depression scale; High-risk pregnancy; Hospitalization

Mesh:

Year:  2016        PMID: 27138949     DOI: 10.1007/s00127-016-1230-7

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  40 in total

1.  Stressful life events, social support, and mood disturbance in hospitalized and non-hospitalized women with pregnancy-induced hypertension.

Authors:  M Heaman
Journal:  Can J Nurs Res       Date:  1992

2.  Prevalence rates and demographic characteristics associated with depression in pregnancy and the postpartum.

Authors:  I H Gotlib; V E Whiffen; J H Mount; K Milne; N I Cordy
Journal:  J Consult Clin Psychol       Date:  1989-04

3.  The validation of the Edinburgh Post-natal Depression Scale on a community sample.

Authors:  L Murray; A D Carothers
Journal:  Br J Psychiatry       Date:  1990-08       Impact factor: 9.319

4.  Does the Edinburgh Postnatal Depression Scale measure anxiety?

Authors:  E P Brouwers; A L van Baar; V J Pop
Journal:  J Psychosom Res       Date:  2001-11       Impact factor: 3.006

5.  Relationship of psychosocial status to low prenatal weight gain among nonobese black and white women delivering at term.

Authors:  C A Hickey; S P Cliver; R L Goldenberg; S F McNeal; H J Hoffman
Journal:  Obstet Gynecol       Date:  1995-08       Impact factor: 7.661

6.  Developmental model of depression applied to prenatal depression: role of present and past life events, past emotional disorders and pregnancy stress.

Authors:  Jacques Dayan; Christian Creveuil; Michel Dreyfus; Michel Herlicoviez; Jean-Marc Baleyte; Veronica O'Keane
Journal:  PLoS One       Date:  2010-09-22       Impact factor: 3.240

7.  Antenatal maternal mental health as determinant of postpartum depression in a population based mother-child cohort (Rhea Study) in Crete, Greece.

Authors:  Katerina Koutra; Maria Vassilaki; Vaggelis Georgiou; Antonios Koutis; Panos Bitsios; Leda Chatzi; Manolis Kogevinas
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-08-21       Impact factor: 4.328

Review 8.  Correlates of anxiety symptoms during pregnancy and association with perinatal outcomes: a meta-analysis.

Authors:  Heather L Littleton; Carmen Radecki Breitkopf; Abbey B Berenson
Journal:  Am J Obstet Gynecol       Date:  2007-05       Impact factor: 8.661

9.  Anxiety, depression and saliva cortisol in women with a medical disorder during pregnancy.

Authors:  Nicole M A King; Jennifer Chambers; Kieran O'Donnell; Samantha R Jayaweera; Catherine Williamson; Vivette A Glover
Journal:  Arch Womens Ment Health       Date:  2010-01-26       Impact factor: 3.633

10.  The Edinburgh Postnatal Depression Scale: translation and validation for a Greek sample.

Authors:  Victoria G Vivilaki; Vassilis Dafermos; Manolis Kogevinas; Panos Bitsios; Christos Lionis
Journal:  BMC Public Health       Date:  2009-09-09       Impact factor: 3.295

View more
  3 in total

1.  Magnitude and Predictors of Antenatal Depression among Pregnant Women Attending Antenatal Care in Sodo Town, Southern Ethiopia: Facility-Based Cross-Sectional Study.

Authors:  Bekalu Thomas Chuma; Getu Gamo Sagaro; Feleke Hailemichael Astawesegn
Journal:  Depress Res Treat       Date:  2020-04-01

2.  Does having a high-risk pregnancy influence anxiety level during the COVID-19 pandemic?

Authors:  Selcan Sinaci; Eda Ozden Tokalioglu; Doga Ocal; Aysegul Atalay; Gamze Yilmaz; Huseyin Levent Keskin; Seval Ozgu Erdinc; Dilek Sahin; Ozlem Moraloglu Tekin
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2020-10-24       Impact factor: 2.435

3.  Effects of a Brief Electronic Mindfulness-Based Intervention on Relieving Prenatal Depression and Anxiety in Hospitalized High-Risk Pregnant Women: Exploratory Pilot Study.

Authors:  Maren Goetz; Claudia Schiele; Markus Wallwiener; Stephanie Wallwiener; Mitho Müller; Lina M Matthies; Thomas M Deutsch; Claudio Spano; Johanna Graf; Stephan Zipfel; Armin Bauer; Sara Y Brucker
Journal:  J Med Internet Res       Date:  2020-08-11       Impact factor: 5.428

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.